Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Modified 'Suicide' stem cells injected into brain to fight aggressive cancer

NCT ID NCT07143812

Summary

This early-stage study is testing the safety of a new treatment for glioblastoma, a fast-growing brain cancer. Doctors inject specially modified donor stem cells directly into the brain after surgery. The goal is to see if these cells can target and kill any remaining cancer cells to help delay the tumor's return.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA (GBM) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Bundang CHA Medical Center

    RECRUITING

    Seongnam, Kyunggido, 13496, South Korea

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.